Lantern Pharma Inc.LTRNNASDAQ
LOADING
|||
EBITDA Over Time
Trending lower, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-22.20M
↓ 107% below average
Average (6y)
$-10.72M
Historical baseline
Range
High:$-1.73M
Low:$-22.20M
CAGR
+53.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-22.20M | -40.6% |
| 2023 | $-15.79M | -9.5% |
| 2022 | $-14.42M | -14.6% |
| 2021 | $-12.58M | -113.1% |
| 2020 | $-5.90M | -143.3% |
| 2019 | $-2.43M | -40.3% |
| 2018 | $-1.73M | - |